Becton Dickinson and Co (NYSE:BDX)
| 248.71 BATS BZX Real-Time Price As of 11:08am ET |  -2.72 / -1.08%Today’s Change | 224.71 Today|||52-Week Range 267.37 | -0.60% Year-to-Date |
Latest BDX News | Press Releases
| 2 Safe Dividend Growth Stocks You Can Buy and Forget About Sep 25 / MotleyFool.com - Paid Partner Content | Cybersecurity Gains Prominence in MedTech: 3 Stocks to Focus on Sep 17 / Zacks.com - Paid Partner Content |
| Here's Why You Should Add Omnicell (OMCL) to Your Portfolio Sep 24 / Zacks.com - Paid Partner Content | 3 Low-Risk Stocks for Conservative Investors Sep 17 / MotleyFool.com - Paid Partner Content |
Today’s Trading
| Previous close | 251.43 |
| Today’s open | 251.06 |
| Day’s range | 247.94 - 251.06 |
| Volume | 352,058 |
| Average volume (3 months) | 1,366,470 |
| Market cap | $72.7B |
Data as of 11:08am ET, 09/28/2021
Growth & Valuation
| Earnings growth (last year) | -31.44% |
| Earnings growth (this year) | +26.52% |
| Earnings growth (next 5 years) | +5.00% |
| Revenue growth (last year) | -1.00% |
| P/E ratio | 39.2 |
| Price/Sales | 3.84 |
| Price/Book | 3.09 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| BSXBoston Scientific Co... | -0.78 | -1.75% |
| DXCMDexcom Inc | -14.49 | -2.64% |
| BAXBaxter International... | -0.16 | -0.20% |
| WSTWest Pharmaceutical ... | -19.12 | -4.33% |
Data as of 11:09am ET, 09/28/2021
Financials
| Next reporting date | November 9, 2021 |
| EPS forecast (this quarter) | $2.44 |
| Annual revenue (last year) | $17.1B |
| Annual profit (last year) | $874.0M |
| Net profit margin | 5.11% |
Profile
Sector Health Technology |
Industry Medical Specialties |
No executives to display |
Corporate headquarters Franklin Lakes, New Jersey |
Forecasts
